NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 63323-0781-41 — Vecuronium bromide 10 mg injectionAI (102 hospitals, 54,202–55,003 samples)
• NDC 63323-0781-44 — Vecuronium injection, a muscle relaxant given by IVAI (89 hospitals, 54,202–55,003 samples)
• NDC 25021-0670-10 — CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTIONAI (125 hospitals, 54,008–54,962 samples)
• NDC 42023-0243-01 — EPHEDRINE SULFATE 5 MG/ML INTRAVENOUS SOLUTIONAI (326 hospitals, 53,578–54,928 samples)
• NDC 47335-0931-40 — Vecuronium bromide injection 10 mgAI (398 hospitals, 54,037–54,919 samples)
• NDC 00781-3493-80 — Dexmedetomidine IV infusion in salineAI (127 hospitals, 54,041–54,896 samples)
• NDC 00409-7299-83 — Sodium acetate intravenous solutionAI (384 hospitals, 53,975–54,893 samples)
• NDC 00641-6238-25 — Ephedrine sulfate injection, 50 mg/mLAI (290 hospitals, 53,897–54,887 samples)
• NDC 63323-0086-15 — Potassium phosphate intravenous solutionAI (270 hospitals, 53,947–54,883 samples)
• NDC 54643-5647-00 — Pediatric multivitamin infusion with vitamin KAI (322 hospitals, 54,050–54,878 samples)
• NDC 69784-0231-10 — Sodium acetate intravenous solutionAI (202 hospitals, 54,025–54,871 samples)
• NDC 43066-0031-01 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (159 hospitals, 53,881–54,844 samples)
• NDC 00143-9232-01 — Vecuronium bromide 20 mg IV injectionAI (74 hospitals, 53,990–54,836 samples)
• NDC 65219-0533-01 — Plant-based (soy) fat emulsion for IV feedingAI (451 hospitals, 54,026–54,827 samples)
• NDC 00409-4888-03 — Sodium chloride 0.9% injection, preservative-freeAI (332 hospitals, 46,671–54,789 samples)
• NDC 00378-6993-31 — Levalbuterol 1.25 mg/0.5 mL nebulizer solutionAI (236 hospitals, 53,830–54,784 samples)
• NDC 00093-6815-19 — Budesonide 0.25 mg per 2 mL nebulizer solutionAI (285 hospitals, 53,830–54,784 samples)
• NDC 70756-0611-82 — Ephedrine sulfate injection, 50 mg/mL vialAI (254 hospitals, 53,830–54,784 samples)
• NDC 69784-0230-20 — Sodium acetate 2 mEq/mL solution, 50 mL vialAI (274 hospitals, 53,976–54,777 samples)
• NDC 65219-0531-01 — Fat emulsion 20%, 100 mL flexible bagAI (289 hospitals, 53,976–54,777 samples)
• NDC 00093-6815-55 — Budesonide 0.25 mg per 2 mL nebulizer solutionAI (308 hospitals, 53,829–54,774 samples)
• NDC 00781-3269-71 — Ephedrine sulfate injection, 50 mg/mLAI (236 hospitals, 53,851–54,769 samples)
• NDC 51754-2004-01 — Potassium acetate intravenous solutionAI (99 hospitals, 53,975–54,767 samples)
• NDC 00409-1098-12 — CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTIONAI (136 hospitals, 53,828–54,764 samples)
• NDC 00409-6695-12 — ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTIONAI (173 hospitals, 53,828–54,764 samples)
• NDC 70710-1644-01 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (80 hospitals, 53,828–54,764 samples)
• NDC 57664-0596-40 — Dexmedetomidine 100 mcg/mL IV solutionAI (73 hospitals, 53,828–54,764 samples)
• NDC 00409-1105-22 — Atracurium injection, 10 mg/mLAI (60 hospitals, 53,828–54,764 samples)
• NDC 00703-2056-03 — Cisatracurium injection (intravenous solution)AI (157 hospitals, 53,719–54,763 samples)
• NDC 51754-2004-04 — Potassium acetate intravenous solutionAI (105 hospitals, 53,965–54,757 samples)
• NDC 80830-1691-02 — Potassium phosphate IV solutionAI (305 hospitals, 53,792–54,728 samples)
• NDC 00641-6261-01 — Sodium acetate injection (IV solution)AI (186 hospitals, 53,843–54,725 samples)
• NDC 71225-0126-03 — Dexmedetomidine IV infusion in salineAI (113 hospitals, 53,814–54,705 samples)
• NDC 71225-0126-06 — Dexmedetomidine IV infusion in salineAI (157 hospitals, 53,814–54,705 samples)
• NDC 00409-1144-62 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (128 hospitals, 53,813–54,695 samples)
• NDC 67457-0228-99 — Rocuronium bromide injection, 100 mg per 10 mLAI (179 hospitals, 53,813–54,695 samples)
• NDC 63323-0269-59 — Propofol intravenous emulsion 500 mg/50 mLAI (280 hospitals, 52,396–54,691 samples)
• NDC 00115-1689-74 — Budesonide 0.5 mg/2 mL nebulizer suspensionAI (170 hospitals, 53,819–54,674 samples)
• NDC 10481-0111-08 — Iodine and potassium iodide solution, 8 mL bottleAI (243 hospitals, 53,818–54,664 samples)
• NDC 00115-1689-76 — Budesonide 0.5 mg/2 mL nebulizer solutionAI (108 hospitals, 53,818–54,664 samples)
• NDC 42571-0313-75 — Verapamil 2.5 mg/mL intravenous injectionAI (83 hospitals, 53,818–54,664 samples)
• NDC 63323-0782-23 — Vecuronium bromide 20 mg injectionAI (106 hospitals, 53,818–54,664 samples)
• NDC 47781-0616-20 — Rocuronium injection 10 mg/mLAI (66 hospitals, 53,818–54,664 samples)
• NDC 63323-0806-11 — Fentanyl (preservative-free) 50 mcg/mL injectionAI (371 hospitals, 39,157–54,655 samples)
• NDC 80830-1691-01 — Potassium phosphate IV solutionAI (273 hospitals, 53,712–54,639 samples)
• NDC 25021-0192-87 — Ciprofloxacin IV antibiotic in dextrose solutionAI (699 hospitals, 52,743–54,633 samples)
• NDC 70121-1585-05 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (140 hospitals, 53,586–54,630 samples)
• NDC 00143-9297-01 — Dantrolene 20 mg intravenous injectionAI (352 hospitals, 53,687–54,605 samples)
• NDC 65219-0531-10 — Intravenous 20% fat emulsionAI (206 hospitals, 53,804–54,605 samples)
• NDC 65219-0533-25 — Intralipid 20% fat emulsion, 250 mL bagAI (444 hospitals, 53,804–54,605 samples)